Physician profile
Yair Lev
NPI 1346403334
$2,255.07
in general payments reported to CMS, 2019-2025
18 companies · $1,079 in 2025
The $1,079 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $16.72 · 2021: $100 · 2022: $195 · 2023: $314 · 2024: $383 · 2025: $1,079.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,776.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $591.03 | 2019-2025 | |
| Amgen INC. | $430.62 | 2019-2025 | Repatha, Repatha |
| Anumana, INC. | $338.33 | 2025 | Ecg-Ai Lef |
| Novo Nordisk INC | $131.68 | 2021-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $102.96 | 2019-2024 | Camzyos, Eliquis |
| Pfizer INC. | $98.29 | 2019-2025 | |
| Atricure, INC. | $90.98 | 2023-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.31 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $84.73 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.38 | 2022 | |
| Impulse Dynamics (USA) INC. | $63.34 | 2023 | Optimizer |
| Alnylam Pharmaceuticals INC. | $43.95 | 2025 | Onpattro |
| Heartflow, INC. | $37.68 | 2025 | |
| Kestra Medical Technology Services, INC. | $28.71 | 2025 | Assure Wcd |
| Philips North America LLC | $21.94 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $17.85 | 2025 | Inspire |
| Abbott Laboratories | $12.29 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yair Lev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.